Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?

Early Human Development

Volumn 87, Issue 2, 2011, Pages 103-107

  van der Weiden, S ^a   de Jong, E P ^a   te Pas, A B ^a   Middeldorp, J M ^a   Vossen, A C T M ^a   Rijken, M ^a   Walther, F J ^a   Lopriore, E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Congenital TORCH infections; Cytomegalovirus; Small for gestational age

Indexed keywords

IMMUNOGLOBULIN M;

ARTICLE; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HERPES SIMPLEX VIRUS; HUMAN; HYDROCEPHALUS; IMMUNOFLUORESCENCE TEST; INFANT; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; MEDICAL RECORD REVIEW; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN SCREENING; NEWBORN SEPSIS; RETROSPECTIVE STUDY; RISK FACTOR; RUBELLA; RUBELLA VIRUS; SCREENING; SERODIAGNOSIS; SEROLOGY; SMALL FOR DATE INFANT; TOXOPLASMA GONDII; TOXOPLASMOSIS; URINE CULTURE;

CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, SMALL FOR GESTATIONAL AGE; MEDICAL FUTILITY; RETROSPECTIVE STUDIES; RUBELLA; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; URINALYSIS; VIROLOGY;

EID: 78751624156     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.11.005     Document Type: Article

References (32)

1. Vandenbosche R.C., Kirchner J.T. Intrauterine growth retardation. Am Fam Physician 1998, 58:1384.
2. Cox P., Marton T. Pathological assessment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009.
3. Bernstein P.S., Divon M.Y. Etiologies of fetal growth restriction. Clin Obstet Gynecol 1997, 40:723-729.
4. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002, 99:490-496.
5. Ananth C.V., Vintzileos A.M. Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Hum Dev 2009, 85:653-658.
6. Breeze A.C., Lees C.C. Prediction and perinatal outcomes of fetal growth restriction. Semin Fetal Neonatal Med 2007, 12:383-397.
7. Khan N.A., Kazzi S.N. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000, 17:131-135.
8. Barker D.J. In utero programming of chronic disease. Clin Sci (Lond) 1998, 95:115-128.
9. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 2006, 194:921-931.
10. Srinivas S.K., Edlow A.G., Neff P.M., Sammel M.D., Andrela C.M., Elovitz M.A. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?. J Perinatol 2009, 29:680-684.
11. Degani S. Sonographic findings in fetal viral infections: a systematic review. Obstet Gynecol Surv 2006, 61:329-336.
12. van der Weiden S., Steggerda S.J., Te Pas A.B., Vossen A.C., Walther F.J., Lopriore E. Routine TORCH screening is not warranted in neonates with subependymal cysts. Early Hum Dev 2010, 86:203-207.
13. de Jong E.P., Lopriore E., Vossen A.C.T.M., Steggerda S.J., Te Pas A.B., Kroes A.C., et al. Is routine TORCH screening warrented in neonates with lenticulostriate vasculopathy?. Neonatology 2009, 97:274-278.
14. Abdel-Fattah S.A., Bhat A., Illanes S., Bartha J.L., Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005, 25:1028-1031.
15. Gaytant M.A., Steegers E.A., Semmekrot B.A., Merkus H.M., Galama J.M. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002, 57:245-256.
16. Cullen A., Brown S., Cafferkey M., O'Brien N., Griffin E. Current use of the TORCH screen in the diagnosis of congenital infection. J Infect 1998, 36:185-188.
17. Lepercq J., Mahieu-Caputo D. Diagnosis and management of intrauterine growth retardation. Horm Res 1998, 49(Suppl 2):14-19.
18. Sheridan C. Intrauterine growth restriction-diagnosis and management. Aust Fam Physician 2005, 34:717-723.
19. Primhak R.A., Simpson R.M. Screening small for gestational age babies for congenital infection. Clin Pediatr (Phila) 1982, 21:417-420.
20. Kloosterman G.J. Intrauterine growth and intrauterine growth curves. Ned Tijdschr Verloskd Gynaecol 1969, 69:349-365.
21. Best J.M., Sutherland S. Diagnosis and prevention of congenital and perinatal infections. BMJ 1990, 301:888-889.
22. Gaytant M.A., Galama J.M., Semmekrot B.A., Melchers W.J., Sporken J.M., Oosterbaan H.P., et al. The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 2005, 76:71-75.
23. Poeran J., Wildschut H., Gaytant M., Galama J., Steegers E., van der M.W. The incidence of neonatal herpes in The Netherlands. J Clin Virol 2008, 42:321-325.
24. Gaytant M.A., Steegers E.A., van Cromvoirt P.L., Semmekrot B.A., Galama J.M. Incidence of herpes neonatorum in Netherlands. Ned Tijdschr Geneeskd 2000, 144:1832-1836.
25. Jenum P.A., Stray-Pedersen B., Melby K.K., Kapperud G., Whitelaw A., Eskild A., et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998, 36:2900-2906.
26. Hahne S., Macey J., van B.R., Kohl R., Dolman S., van d V., et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J 2009, 28:795-800.
27. Nellhaus G. Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics 1968, 41:106-114.
28. Matthews T.G., O'Herlihy C. Significance of raised immunoglobulin M levels in cord blood of small-for-gestational-age infants. Arch Dis Child 1978, 53:895-898.
29. Commey J.O., Fitzhardinge P.M. Handicap in the preterm small-for-gestational age infant. J Pediatr 1979, 94:779-786.
30. Weiner C.P., Williamson R.A. Evaluation of severe growth retardation using cordocentesis-hematologic and metabolic alterations by etiology. Obstet Gynecol 1 1989, 73:225-229.
31. Vik T., Vatten L., Markestad T., Ahlsten G., Jacobsen G., Bakketeig L.S. Morbidity during the first year of life in small for gestational age infants. Arch Dis Child Fetal Neonatal Ed 1996, 75:F33-F37.
32. Lopriore E., van Wezel-Meijler G., Middeldorp J.M., Sueters M., Vandenbussche F.P., Walther F.J. Incidence, origin, and character of cerebral injury in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Am J Obstet Gynecol 2006, 194:1215-1220.